Motokazu Tsujikawa

This study screens FDA-approved drugs in a zebrafish model of autosomal dominant retinitis pigmentosa, identifying four compounds that improve visual behavior by distinct mechanisms.

This study evaluates matricization and feature selection methods for analyzing multi-dimensional tensor behavioral data from zebrafish, showing improved classification performance and revealing new behavioral differences.

This study screens drugs using zebrafish visual behavior to identify carvedilol as a potential treatment for retinitis pigmentosa.

This study uses GWAS to identify Mendelian and non-Mendelian variants associated with retinitis pigmentosa, uncovering new genetic causes and therapeutic targets.